Inhibitory Effects of Cyclosporine on Human Regulatory T Cells In Vitro

Transplantation Proceedings

Volumn 41, Issue 8, 2009, Pages 3371-3374

  Miroux, C ^a   Morales O ^b   Carpentier, A ^b   Dharancy, S ^c   Conti, F ^b   Boleslowski, E ^c   Podevin, P ^c   Auriault, C ^d   Pancre V ^a   Delhem, N ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b Institut Cochin   (United States)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVITY; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOLATION PROCEDURE; MIXED LYMPHOCYTE REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

EID: 70350502187     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.08.043     Document Type: Article

References (12)

1. Lamelin J.P., Zoulim F., and Trepo C. Lymphotropism oh hepatitis B and C viruses: an update and a newcomer. Int J Clin Lab Res 25 (1995) 11
2. Charlton M. Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus reccurence. Liver Transplant 9 (2003) S58
3. Carpentier A., Conti F., Podevin P., et al. Increased activity of regulatory T cells in recurrent hepatitis C after liver transplantation. Hepatology 44 suppl 1 (2006) 86
4. Rayhill S.C., Barbeito R., Katz D., et al. A cyclosporine-based immunosuppression regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. Transplant Proc 38 (2006) 3625
5. Villamil F., Levy G., Grazi G.L., et al. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine. Transplant Proc 38 (2006) 2964
6. Fontenot J.D., Rasmussen J.P., Gavin M.A., et al. A function for interleukin 2 in Foxp3- expressing regulatory T cells. Nat Immunol 6 (2005) 1142
7. Kawai M., Kitade H., Mathieu C., et al. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 79 (2005) 1073
8. Hoffmann P., Eder R., Kunz-Schughart L.A., et al. Large-scale in vitro expansion of polyclonal human CD4+CD25 high regulatory T cells. Blood 104 (2004) 895
9. Seddiki N., Santner-Nanan B., Martinson J., et al. Expression of interleukin IL-2 and IL-7 receptors discriminates human regulatory and activated T cells. J Exp Med 203 (2006) 1693
10. Wang H., Zhao L., Sun Z., et al. A potential side effect of Cyclosporin A: inhibition of CD4+CD25+ regulatory T cells in mice. Transplantation 82 (2006) 1484
11. San Segundo D.S., Ruiz J.C., Fernandez-Fresnedo G., et al. Calcineurin inhibitors affect circulating regulatory T cells in stable renal transplant recipients. Transplant Proc 38 (2006) 2391
12. Zeiser R., Nguyen V.H., Beilhack A., et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108 (2006) 390